Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03987490 · ClinicalTrials.gov registry record · NA

Usability of HPV Vaccine Reminders

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
325
Enrollment target

NCT03987490: Completed NA study, sponsored by University of Florida.

NCT03987490 is a NA study that has completed, run by University of Florida. The registered enrollment target is 325 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03987490, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
325 participants
Enrollment target

Study Summary

This study will assess the usefulness of parent-targeted strategies in improving care seeking among parents of 11-12 year old adolescents. Specifically, the study team will focus on reminders (postcard or text message) and motivational interviewing to improve adolescent vaccination.

Primary Outcome

Percentage of Patients with deliverable text messages

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Text Message
  • BEHAVIORAL Motivational Interview
  • BEHAVIORAL PostCard

Trial Details

FieldValue
Enrollment Target 325 participants
Start Date 2015-12-01
Est. Completion 2016-12-15
Phase NA
University of Florida

1,106 total trials

What the finished NCT03987490 record still lists

NCT03987490 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 4 interventions - of which Standard of Care is the first listed.

NCT03987490 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03987490 about?

NCT03987490 is a clinical study titled "Usability of HPV Vaccine Reminders". This study will assess the usefulness of parent-targeted strategies in improving care seeking among parents of 11-12 year old adolescents. Specifically, the study team will focus on reminders (postcard or text message) and motivational interviewing to improve adolescent vaccination.

What is the current status of trial NCT03987490?

This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2015-12-01. Estimated completion is 2016-12-15.

What interventions are being tested in trial NCT03987490?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Text Message (BEHAVIORAL), Motivational Interview (BEHAVIORAL), PostCard (BEHAVIORAL).

Who is sponsoring clinical trial NCT03987490?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03987490's enrollment target sits among peer trials

325 311th of 2000 higher than 1,689 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02543983 · 325 participants · Phase 2

    Neurobiology of Suicide

  • NCT03016819 · 325 participants · Phase 3

    Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  • NCT03288207 · 325 participants · NA

    Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

  • NCT04986657 · 325 participants · NA

    Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03987490, the US trial registry maintained by the National Library of Medicine. NCT03987490 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.